| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Thomas M Kündig | Q105045997 |
| P2093 | author name string | Pål Johansen | |
| Gabriela Senti | |||
| Tazio Storni | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 333-355 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Immunity in response to particulate antigen-delivery systems | |
| P478 | volume | 57 |
| Q50645925 | A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum. |
| Q79164480 | Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis |
| Q50698838 | Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5. |
| Q89983778 | Advanced biomaterials for cancer immunotherapy |
| Q40463159 | An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes. |
| Q51190424 | An investigation into the adjuvanticity and immunogenicity of zein microspheres being researched as drug and vaccine carriers |
| Q36516144 | Antigen kinetics determines immune reactivity |
| Q38212549 | Applying biodegradable particles to enhance cancer vaccine efficacy |
| Q47323461 | Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases. |
| Q36582010 | Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles |
| Q41468156 | Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma |
| Q39624231 | Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination |
| Q80453310 | Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration |
| Q39117175 | Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy |
| Q33746872 | Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses |
| Q27490878 | Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB |
| Q46577167 | Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum |
| Q38912004 | Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy? |
| Q35812875 | Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens |
| Q37062606 | Design opportunities for actively targeted nanoparticle vaccines |
| Q46040427 | Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery |
| Q39426740 | EFFECTS OF COMBRETUM HEREROENSE AND CANTHIUMMUNDIANUM water EXTRACTS ON PRODUCTION AND EXPRESSION OF INTERLEUKIN-4. |
| Q36941463 | Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation |
| Q47376862 | Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines |
| Q45052268 | Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density. |
| Q86953818 | Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research |
| Q38765636 | Enhancing vaccine effectiveness with delivery technology |
| Q45375987 | Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus |
| Q33650861 | Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity |
| Q46043845 | Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits |
| Q59342615 | From single-dose vaccine delivery systems to nanovaccines |
| Q26782563 | Gas Vesicle Nanoparticles for Antigen Display |
| Q37077649 | Genetically engineered Tobacco mosaic virus as nanoparticle vaccines |
| Q34515009 | Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine development |
| Q81474067 | Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens |
| Q88544181 | Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins |
| Q50060583 | Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex |
| Q36160348 | Immunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles |
| Q34057755 | Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles |
| Q50709309 | Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. |
| Q51031693 | Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity |
| Q90239711 | In Staphylococcus aureus, the Particulate State of the Cell Envelope Is Required for the Efficient Induction of Host Defense Responses |
| Q46514400 | In vivo activity of cationic immune stimulating complexes (PLUSCOMs). |
| Q33944432 | Induction of boosted immune response in mice by leptospiral surface proteins expressed in fusion with DnaK. |
| Q34482487 | Induction of protective anti-CTL epitope responses against HER-2-positive breast cancer based on multivalent T7 phage nanoparticles |
| Q64118404 | Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide |
| Q40360053 | Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model. |
| Q38729260 | Liposomal adjuvants for human vaccines |
| Q36602259 | Liposomal vaccines--targeting the delivery of antigen |
| Q46441246 | Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres |
| Q38032881 | Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines |
| Q28396375 | Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications |
| Q38266149 | Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy |
| Q26767037 | Microneedles: A New Frontier in Nanomedicine Delivery |
| Q38330161 | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
| Q26748776 | Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems |
| Q37642613 | Mucosal vaccines: recent progress in understanding the natural barriers. |
| Q51068276 | Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy. |
| Q60222601 | Murine CD8+T cell cytotoxicity against schistosomula induced by inoculation of schistosomal 22.6/26GST coupled Sepharose 4B beads |
| Q38517950 | Nanoengineering of vaccines using natural polysaccharides. |
| Q37890639 | Nanomedicine: novel approaches in human and veterinary therapeutics |
| Q58699988 | Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype |
| Q40015848 | Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells |
| Q42009342 | Nanoparticles: Emerging carriers for drug delivery |
| Q35836140 | Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. |
| Q43442849 | Nanoscale size control of protein aggregates |
| Q47954878 | Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity |
| Q38162231 | Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status |
| Q36277327 | OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp |
| Q27493140 | Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses |
| Q60243630 | Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes |
| Q97593286 | Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores |
| Q38777042 | Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response. |
| Q35983565 | Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity |
| Q45074067 | Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction |
| Q38162184 | Recent developments in liposome-based veterinary therapeutics |
| Q42261896 | Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination. |
| Q38400992 | Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery |
| Q64881146 | Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches. |
| Q58559836 | Single dose of polyanhydride particle-based vaccine generates potent antigen-specific antitumor immune responses |
| Q37607079 | Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses |
| Q53258287 | Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. |
| Q36316814 | Starch microparticles as vaccine adjuvant |
| Q54270408 | Suppression of splenic lymphocyte proliferation by Eucommia ulmoides and genipin. |
| Q82592385 | Surface modification of poly(D,L‐lactic‐co‐glycolic acid) nanoparticles with protamine enhanced cross‐presentation of encapsulated ovalbumin by bone marrow‐derived dendritic cells |
| Q38982074 | Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation |
| Q40147137 | The Immune Adjuvant Effects of Flounder (Paralichthys olivaceus) Interleukin-6 on E. tarda Subunit Vaccine OmpV. |
| Q43100143 | The effects of Saccharum officinarium (sugar cane) molasses on cytokine secretion by human blood cultures |
| Q42627924 | The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine |
| Q50054197 | The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model |
| Q38404208 | Toward a Single-Dose Vaccination Strategy with Self-Encapsulating PLGA Microspheres |
| Q35972642 | Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11 |
| Q36750711 | Vaccine adjuvants revisited |
| Q36712817 | Vaccine delivery using nanoparticles. |
| Q39261291 | Whole Pichia pastoris yeast expressing measles virus nucleoprotein as a production and delivery system to multimerize Plasmodium antigens |
| Q41544524 | mRNA delivery using non-viral PCL nanoparticles. |
Search more.